M. Margarida Bernardo

Cited by

	All	Since 2019
Citations	4904	1018
h-index	34	19
i10-index	47	33

280

140

210

1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202413 35 17 23 38 73 103 126 189 222 236 237 244 243 203 232 231 270 242 192 201 205 199 197 206 185 183 159 88

Public access

View all

17 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Shahriar MobasheryUniversity of Notre DameVerified email at nd.edu
R. Daniel BonfilProfessor of Pathology, Nova Southeastern University College of Allopathic MedicineVerified email at nova.edu
Yves DeClerckProfessor of Pediatrics and Biochemistry and Molecular BiologyVerified email at usc.edu
Alexander KaplunVariantyxVerified email at variantyx.com
Q. Sang, QX. Amy Sang (Qing-Xiang A...Florida State University, Department of Chemistry & BiochemistryVerified email at chem.fsu.edu
Duanqing PeiWestlake UniversityVerified email at westlake.edu.cn
Christopher M OverallUniversity of British ColumbiaVerified email at ubc.ca
Jose Carlos Trindade FilhoProfessor Assistente Doutor, UNESPVerified email at fmb.unesp.br
Kang ChenWayne State UniversityVerified email at wayne.edu
Bonnie F. SloaneDistinguished Professor of Pharmacology, Wayne State UniversityVerified email at med.wayne.edu
Samy MerouehProfessor of Biochemistry, University of Illinois Urbana-ChampaignVerified email at illinois.edu
Luis F. TeixeiraAssociate Professor, Universidade do PortoVerified email at fe.up.pt
José Luis FougoFaculdade de Medicina, Porto UniversityVerified email at chsj.min-saude.pt
Jaime CardosoFull Professor at Faculty of Engineering, University of Porto; Researcher, INESC TECVerified email at fe.up.pt
David ChristieRadiation oncologistVerified email at genesiscare.com.au
Jin Ah ChoHarvard UniversityVerified email at childrens.harvard.edu
Kiran V. Mahasenan, PhDKymera TherapeuticsVerified email at kymeratx.com
Semir VranićCMED, Qatar University & Academy of Sciences and Arts of Bosnia&HerzegovinaVerified email at qu.edu.qa
Claudia MartiniProfessor of Biochemistry, Department of Pharmacy, University of PisaVerified email at unipi.it
Armando RosselloFull Professor of Medicinal Chemistry, Università di Pisa, Dipartimento di FarmaciaVerified email at farm.unipi.it

M. Margarida Bernardo

Scientist-Project Manager, WSU School of Medicine, Karmanos Cancer Institute

Verified email at med.wayne.edu

Animal Tumor Models Tissue Analysis 3D Matrix Models Organotypic Drug Screening Functional Confocal Imaging


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 … S Hernandez-Barrantes, M Toth, MM Bernardo, M Yurkova, DC Gervasi, ... Journal of Biological Chemistry 275 (16), 12080-12089, 2000	390	2000
Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes M Toth, I Chvyrkova, MM Bernardo, S Hernandez-Barrantes, R Fridman Biochemical and biophysical research communications 308 (2), 386-395, 2003	273	2003
Potent and selective mechanism-based inhibition of gelatinases S Brown, MM Bernardo, ZH Li, LP Kotra, Y Tanaka, R Fridman, ... Journal of the American Chemical Society 122 (28), 6799-6800, 2000	258	2000
TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 … MM Bernardo, R Fridman Biochemical Journal 374 (3), 739-745, 2003	255	2003
Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3 … XW Liu, MM Bernardo, R Fridman, HRC Kim Journal of Biological Chemistry 278 (41), 40364-40372, 2003	237	2003
Regulation of membrane type-matrix metalloproteinases S Hernandez-Barrantes, M Bernardo, M Toth, R Fridman Seminars in cancer biology 12 (2), 131-138, 2002	232	2002
Turning subjective into objective: the BCCT. core software for evaluation of cosmetic results in breast cancer conservative treatment MJ Cardoso, J Cardoso, N Amaral, I Azevedo, L Barreau, M Bernardo, ... The Breast 16 (5), 456-461, 2007	216	2007
Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9: differential rates for activation by stromelysin 1 MW Olson, MM Bernardo, M Pietila, DC Gervasi, M Toth, LP Kotra, ... Journal of Biological Chemistry 275 (4), 2661-2668, 2000	212	2000
Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 … H Zhao, MM Bernardo, P Osenkowski, A Sohail, D Pei, H Nagase, ... Journal of Biological Chemistry 279 (10), 8592-8601, 2004	184	2004
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1 … M Toth, MM Bernardo, DC Gervasi, PD Soloway, Z Wang, HF Bigg, ... Journal of Biological Chemistry 275 (52), 41415-41423, 2000	172	2000
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor A Krüger, MJE Arlt, M Gerg, C Kopitz, MM Bernardo, M Chang, ... Cancer research 65 (9), 3523-3526, 2005	170	2005
MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer A Sohail, Q Sun, H Zhao, MM Bernardo, JA Cho, R Fridman Cancer and Metastasis reviews 27, 289-302, 2008	165	2008
Complex pattern of membrane type 1 matrix metalloproteinase shedding: regulation by autocatalytic cell surface inactivation of active enzyme M Toth, S Hernandez-Barrantes, P Osenkowski, MM Bernardo, ... Journal of Biological Chemistry 277 (29), 26340-26350, 2002	156	2002
Potent mechanism-based inhibitors for matrix metalloproteinases M Ikejiri, MM Bernardo, RD Bonfil, M Toth, M Chang, R Fridman, ... Journal of Biological Chemistry 280 (40), 33992-34002, 2005	155	2005
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue Z Dong, RD Bonfil, S Chinni, X Deng, JC Trindade Filho, M Bernardo, ... The American journal of pathology 166 (4), 1173-1186, 2005	138	2005
Mucinous carcinoma of the breast: a pathologic study of 82 cases S André, F Cunha, J Soares, M Bernardo, JM E Sousa, F Cortez Journal of surgical oncology 58 (3), 162-167, 1995	125	1995
Comparison of the influence of saturated nitrogen and sulfur donor atoms on the properties of copper (II/I)-macrocyclic polyamino polythiaether ligand complexes: redox … MM Bernardo, MJ Heeg, RR Schroeder, LA Ochrymowycz, ... Inorganic Chemistry 31 (2), 191-198, 1992	113	1992
Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism‐based selective gelatinase inhibitor RD Bonfil, A Sabbota, S Nabha, MM Bernardo, Z Dong, H Meng, ... International journal of cancer 118 (11), 2721-2726, 2006	105	2006
Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases MM Bernardo, S Brown, ZH Li, R Fridman, S Mobashery Journal of Biological Chemistry 277 (13), 11201-11207, 2002	104	2002
X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor: Comparison with the latent and active forms of the … O Kleifeld, LP Kotra, DC Gervasi, S Brown, MM Bernardo, R Fridman, ... Journal of Biological Chemistry 276 (20), 17125-17131, 2001	104	2001

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors